Position in AXGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,550,415
+$12,177,352 QoQ
Shares Held
336,662
+230.7% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 253 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $2,448,266,370 across 55 Medical Devices names. AXGN ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
7,113,902 | $556,520,550 | |
| 2 | ABT |
Abbott Laboratories
|
5,023,587 | $455,840,283 | |
| 3 | SYK |
Stryker Corp
|
987,906 | $311,032,323 | |
| 4 | EW |
Edwards Lifesciences Corp
|
2,427,083 | $219,553,926 | |
| 5 | DXCM |
Dexcom Inc
|
3,087,990 | $207,976,124 | |
| 6 | STE |
STERIS plc
|
603,153 | $127,005,925 | |
| 7 | BSX |
Boston Scientific Corp
|
1,923,305 | $82,086,656 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
866,170 | $74,568,573 |
All Filings in AXGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,550,415 | 336,662 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,373,063 | 101,813 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,980,065 | 121,603 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $2,745,182 | 153,878 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,683,734 | 155,183 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,701,385 | 254,129 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,551,774 | 276,200 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||